As businesses continue to respond to COVID-19, conversations on reshaping investment ecosystems and catalysing partnerships are essential. But nonetheless, the scale-up of effective, quality health innovations require a better understanding of barriers to implementation and uptake to reach the most vulnerable populations. Malyse Uwase, East Africa Senior Consultant at Salient Advisory joins CNBC Africa for more.